The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2023

Filed:

Aug. 16, 2017
Applicant:

Autolus Limited, London, GB;

Inventors:

Vijay Peddareddigari, London, GB;

Richard Beswick, London, GB;

John Short, London, GB;

Martin Pulé, London, GB;

Ekaterini Kotsopoulou, London, GB;

Assignee:

AUTOLUS LIMITED, London, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/867 (2006.01); C12N 5/0783 (2010.01); C12N 15/62 (2006.01); C07K 16/28 (2006.01); A61P 35/00 (2006.01); A61K 38/00 (2006.01); C12N 15/86 (2006.01); C07K 14/725 (2006.01); C07K 14/00 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 14/00 (2013.01); C07K 14/7051 (2013.01); C07K 14/70596 (2013.01); C07K 16/2809 (2013.01); C07K 16/2818 (2013.01); A61K 38/00 (2013.01); C07K 2317/10 (2013.01); C07K 2317/622 (2013.01); C07K 2317/75 (2013.01); C12N 2740/13032 (2013.01); C12N 2740/13045 (2013.01); C12N 2740/13052 (2013.01); C12N 2740/15023 (2013.01); C12N 2740/15032 (2013.01); C12N 2740/15043 (2013.01); C12N 2740/15045 (2013.01); C12N 2740/15052 (2013.01); C12N 2810/852 (2013.01); C12N 2810/855 (2013.01); C12N 2810/859 (2013.01);
Abstract

The present invention provides a retroviral or lentiviral vector having a viral envelope which comprises a mitogenic T-cell activating transmembrane protein which comprises: (i) a mitogenic domain which binds a mitogenic tetraspanin, and (ii) a transmembrane domain; wherein the mitogenic T-cell activating transmembrane protein is not part of a viral envelope glycoprotein. When cells such as T-cells or Natural Killer cells are transduced by such a viral vector, they are activated by the mitogenic T-cell activating transmembrane protein.


Find Patent Forward Citations

Loading…